Comparative evaluation of neonatal bilirubin using Radiometer whole blood co-oximetry and plasma bilirubin methods from Roche Diagnostics and Ortho Clinical Diagnostics

Abstract

BackgroundClinically significant variation has been reported within and between plasma and whole blood total bilirubin methods used to identify neonates for whom clinical intervention for hyperbilirubinemia may be required. ObjectiveTo evaluate total bilirubin measurements between the Radiometer whole blood co-oximeter and plasma bilirubin methods from Roche Diagnostics and Ortho Clinical Diagnostics using neonatal specimens. MethodsTotal bilirubin levels were analyzed by whole blood co-oximetry (Radiometer® ABL90). Specimens were centrifuged and plasma analyzed for total bilirubin with a diazo method (Roche Cobas® C-601) and a reflectance spectrophotometric BuBc dry film method (Ortho Clinical Diagnostics VITROS® 350). Results were evaluated by regression, Bland-Altman comparisons and t-tests. ResultsThe patient correlation study yielded the following regression equations in μmol/L: a) Radiometer=1.03 Roche – 3.5μmol/L b) Radiometer=0.98 Ortho – 5.7μmol/L c) Roche=0.97 Ortho – 2.4μmol/L. The mean bias over the range of total bilirubin levels examined was −1.0μmol/L for the Radiometer versus the Roche (p≤0.305); −4.4μmol/L for the Radiometer versus Ortho (p≤0.005) and −4.4μmol/L for the Roche versus Ortho (p≤0.002). ConclusionsWhole blood total bilirubin measurement using the Radiometer ABL90 blood gas analyzer provides accurate and precise results compared to the Roche plasma diazo method. Compared to the reflectance spectrophotometric method, results are precise and had a small but statistically significant bias of −4.4μmol/L.